Role of the Endocannabinoid/Endovanilloid System in the Modulation of Osteoclast Activity in Paget’s Disease of Bone
Open Access
- 21 September 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (18) , 10158
Abstract
The role of the endocannabinoid/endovanilloid (EC/EV) system in bone metabolism has recently received attention. Current literature evidences the modulation of osteoclasts and osteoblasts through the activation or inhibition of cannabinoid receptors in various pathological conditions with secondary involvement of bone tissue. However, this role is still unclear in primary bone diseases. Paget’s disease of the bone (PDB) could be considered a disease model for analyzing the role of the EC/EV system on osteoclasts (OCs), speculating the potential use of specific agents targeting this system for managing metabolic bone disorders. The aim of the study is to analyze OCs expression of EC/EV system in patients with PDB and to compare OCs activity between this population and healthy people. Finally, we investigate whether specific agents targeting EC/EV systems are able to modulate OCs activity in this metabolic bone disorder. We found a significant increase in cannabinoid receptor type 2 (CB2) protein expression in patients with PDB, compared to healthy controls. Moreover, we found a significant reduction in multi-nucleated tartrate-resistant acid phosphatase (TRAP)–positive OCs and resorption areas after treatment with JWH-133. CB2 could be a molecular target for reducing the activity of OCs in PDB, opening new therapeutic scenarios for the management of this condition.Keywords
This publication has 26 references indexed in Scilit:
- A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 yearsJournal of Bone and Mineral Research, 2011
- Comparison of intravenous and intramuscular neridronate regimens for the treatment of paget disease of boneJournal of Bone and Mineral Research, 2010
- Paget’s disease of bone: a review of epidemiology, pathophysiology and managementTherapeutic Advances in Musculoskeletal Disease, 2009
- The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorptionBone, 2009
- Why endocannabinoids are not all alikeNature Neuroscience, 2008
- CB2receptor‐mediated migration of immune cells: it can go either wayBritish Journal of Pharmacology, 2008
- The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signalingThe FASEB Journal, 2007
- Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptorsNature Medicine, 2005
- Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.Journal of Clinical Investigation, 1990
- Nuclear Inclusions in Paget's Disease of BoneScience, 1976